Abstract

The screening of hair follicles, dermal papilla cells, and keratinocytes through in vitro, in vivo, and histology has previously been reported to combat alopecia. Ficus benghalensis has been used conventionally to cure skin and hair disorders, although its effect on 5α-reductase II is still unknown. Currently, we aim to analyze the phytotherapeutic impact of F. benghalensis leaf extracts (FBLEs) for promoting hair growth in rabbits along with in vitro inhibition of the steroid isozyme 5α-reductase II. The inhibition of 5α-reductase II by FBLEs was assessed by RP-HPLC, using the NADPH cofactor as the reaction initiator and Minoxin (5%) as a positive control. In silico studies were performed using AutoDock Vina to visualize the interaction between 5α-reductase II and the reported phytoconstituents present in FBLEs. Hair growth in female albino rabbits was investigated by applying an oral dose of the FBLE formulation and control drug to the skin once a day. The skin tissues were examined by histology to see hair follicles. Further, FAAS, FTIR, and antioxidants were performed to check the trace elements and secondary metabolites in the FBLEs. The results of RP-HPLC and the binding energies showed that FBLEs reduced the catalytic activity of 5α-reductase II and improved cell proliferation in rabbits. The statistical analysis (p < 0.05 or 0.01) and percentage inhibition (>70%) suggested that hydroalcoholic FBLE has more potential in increasing hair growth by elongating hair follicle’s anagen phase. FAAS, FTIR, and antioxidant experiments revealed sufficient concentrations of Zn, Cu, K, and Fe, together with the presence of polyphenols and scavenging activity in FBLE. Overall, we found that FBLEs are potent in stimulating hair follicle maturation by reducing the 5α-reductase II action, so they may serve as a principal choice in de novo drug designing to treat hair loss.

Highlights

  • The term androgenic alopecia (AGA) refers to the patterned loss of scalp hair in men and women due to heredity and hormonal factors (Abbas et al, 2021)

  • We found that F. benghalensis leaf extracts (FBLEs) are potent in stimulating hair follicle maturation by reducing the 5α-reductase II action, so they may serve as a principal choice in de novo drug designing to treat hair loss

  • Treatment of AGA has been an open debate in clinical dermatology for many years

Read more

Summary

Introduction

The term androgenic alopecia (AGA) refers to the patterned loss of scalp hair in men and women due to heredity and hormonal factors (Abbas et al, 2021). Factors causing AGA are androgen hormonal imbalance, stress, genetic disorders, malnutrition, chemotherapy, 5α-reductase II (SRD5AII) overactivity, thyroid malfunctioning, drug addiction, ageing, and malignancy (Richards et al, 2008). Many therapies are available to combat baldness, like hair transplant through bioengineering (Asakawa et al, 2012), HF regeneration by rearranging stem cells (Toyoshima et al, 2012), platelet-rich plasma (PRP) (Cervantes et al, 2018), and synthetic drugs minoxidil and finasteride (Roy et al, 2008; Gregoriou et al, 2010). A correlation was observed between plasma micronutrients, vitamin deficiency, and hair density in nongenetic patients with AGA by direct colorimetric tests and flame atomic absorption spectrophotometry (FAAS) (Kondrakhina et al, 2020)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call